E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) General Information

Description

A distribution and sale license for a pharmaceutical grade HFC-227ea/P product. The product is used to deliver a variety of drugs and medications in aerosol form such as use in metered-dose inhalers for treatment of asthma.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Distributors (Healthcare)
Other Commercial Services
Acquirer
Orbia Advance
Primary Office
  • 1007 Market Street
  • Wilmington, DE 19898
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product)‘s full profile, request access.

Request a free trial

E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product)‘s full profile, request access.

Request a free trial